Doctor on AstraZeneca's COVID-19 vaccine trial results, risk of spring break surge

Doctor on AstraZeneca's COVID-19 vaccine trial results, risk of spring break surgeПодробнее

Doctor on AstraZeneca's COVID-19 vaccine trial results, risk of spring break surge

AstraZeneca vaccine 79 percent effective at preventing COVID symptoms, U.S. trial showsПодробнее

AstraZeneca vaccine 79 percent effective at preventing COVID symptoms, U.S. trial shows

AstraZeneca scrambles to address concerns about vaccine efficacy dataПодробнее

AstraZeneca scrambles to address concerns about vaccine efficacy data

COVID Vaccine - AstraZeneca Phase III Trials Interim ResultsПодробнее

COVID Vaccine - AstraZeneca Phase III Trials Interim Results

AstraZeneca Vaccine Trials In U.S. Show Highly Effective Results Against COVID-19Подробнее

AstraZeneca Vaccine Trials In U.S. Show Highly Effective Results Against COVID-19

AstraZeneca says its COVID-19 vaccine is safe and highly effective after U.S. clinical trialПодробнее

AstraZeneca says its COVID-19 vaccine is safe and highly effective after U.S. clinical trial

Doctor weighs in on AstraZeneca pausing its coronavirus vaccine trialПодробнее

Doctor weighs in on AstraZeneca pausing its coronavirus vaccine trial

U.S. health officials cast doubt over AstraZeneca trial resultsПодробнее

U.S. health officials cast doubt over AstraZeneca trial results

Doctor on U.S. health officials questioning AstraZeneca vaccine clinical trial resultsПодробнее

Doctor on U.S. health officials questioning AstraZeneca vaccine clinical trial results

Fauci: 'Good news' from AstraZeneca vaccine studyПодробнее

Fauci: 'Good news' from AstraZeneca vaccine study

AstraZeneca's coronavirus vaccine found to be 79% effective with no increased risk of blood clottingПодробнее

AstraZeneca's coronavirus vaccine found to be 79% effective with no increased risk of blood clotting

U.S. trial: AstraZeneca vaccine 79% effective as TN moves into phase 2a and 2bПодробнее

U.S. trial: AstraZeneca vaccine 79% effective as TN moves into phase 2a and 2b

Video: Massachusetts doctor sets record straight on AstraZeneca COVID-19 vaccine trialПодробнее

Video: Massachusetts doctor sets record straight on AstraZeneca COVID-19 vaccine trial

WHO issues recommendations on the AstraZeneca COVID-19 vaccineПодробнее

WHO issues recommendations on the AstraZeneca COVID-19 vaccine

Concerns over AstraZeneca’s COVID-19 vaccine dataПодробнее

Concerns over AstraZeneca’s COVID-19 vaccine data

AstraZeneca vaccine found to be 79% effective in U.S. trialПодробнее

AstraZeneca vaccine found to be 79% effective in U.S. trial

Dr. Oz: AstraZeneca COVID-19 VaccineПодробнее

Dr. Oz: AstraZeneca COVID-19 Vaccine

U.S. study finds AstraZeneca vaccine 79% effective against symptomatic COVID-19Подробнее

U.S. study finds AstraZeneca vaccine 79% effective against symptomatic COVID-19

Oxford-AstraZeneca trial shows its vaccine is 79% effectiveПодробнее

Oxford-AstraZeneca trial shows its vaccine is 79% effective

AstraZeneca’s COVID-19 vaccine and clotting risksПодробнее

AstraZeneca’s COVID-19 vaccine and clotting risks